Mathematical modeling of type 1 diabetes in the NOD mouse: separating incidence and age of onset
James R. Moore, Fred Adler

TL;DR
This paper presents a mathematical model of immune interactions in NOD mice to explain variability in T1D development, identifying factors influencing disease incidence and age of onset, and validating the model with experimental data.
Contribution
The authors develop a simple yet effective mathematical model that distinguishes stable immune states in NOD mice and analyzes factors affecting T1D incidence and onset age.
Findings
Mice can be in mild or severe insulitis states with different progression outcomes.
Sensitivity analysis identifies key parameters influencing disease incidence and age of onset.
Model reproduces multiple experimental phenomena with few equations.
Abstract
Type 1 diabetes (T1D) is an autoimmune disease of the beta cells of the pancreas. The nonobese diabetic (NOD) mouse is a commonly used animal model, with roughly an 80% incidence rate of T1D among females. In 100% of NOD mice, macrophages and T-cells invade the islets in a process called insulitis. It can be several weeks between insulitis and T1D, and some mice do not progress at all. It is thought that this delay is mediated by regulatory T-cells (Tregs) and that a gradual loss of effectiveness in this population leads to T1D. However, this does not explain why some mice progress and others do not. We propose a simple mathematical model of the interaction between beta cells and the immune populations, including regulatory T-cells. We find that individual mice may enter one of two stable steady states: a `mild' insulitis state that does not progress to T1D and a `severe' insulitis…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDiabetes and associated disorders · Pancreatic function and diabetes · Diabetes Management and Research
